AUSF - ETF AI Analysis
Top Page
Global X Adaptive U.S. Factor ETF (AUSF)
Rating:71Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors like financials, technology, health care, and consumer stocks, which can help reduce the impact if one area of the market struggles.
Strong Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, suggesting its strategy has been working well in the current market.
Solid, Well-Performing Top Holdings
Several of the largest positions, including well-known companies in communication services, technology, consumer staples, and health care, have delivered strong year-to-date results that support the fund’s overall performance.
Negative Factors
High U.S.-Only Exposure
Almost all of the fund’s assets are invested in U.S. companies, so it offers little diversification across different countries and economies.
Moderate Expense Ratio
The fund’s fee is not especially high but is also not among the very cheapest ETFs, which slightly reduces the net return investors keep over time.
Meaningful Sector Tilts
The ETF leans more heavily into areas like financials and technology, which could hurt performance if these sectors fall out of favor in the market.
AUSF vs. SPDR S&P 500 ETF (SPY)
AUM861.88M
RegionNorth America
Expense Ratio0.27%
Beta0.58
IssuerGlobal X
Inception DateAug 24, 2018
Dividend Yield2.69%
Asset ClassEquity
Index TrackedAdaptive Wealth Strategies U.S. Factor Index (USD)
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume62,499
30 Day Avg. Volume79,890
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.51Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering192
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AUSF Summary
The Global X Adaptive U.S. Factor ETF (AUSF) tracks the Adaptive Wealth Strategies U.S. Factor Index, which aims to cover the whole U.S. stock market while tilting toward stocks that look attractive based on value, momentum, and volatility. It holds a wide mix of companies across many sectors, including well-known names like Walmart, Johnson & Johnson, Verizon, and AT&T. Someone might invest in AUSF for broad U.S. diversification with a rules-based approach that tries to adjust as markets change. A key risk is that it still invests in stocks, so its value can go up and down with the overall market.
How much will it cost me?The Global X Adaptive U.S. Factor ETF (AUSF) has an expense ratio of 0.27%, which means you’ll pay $2.70 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed strategy to adapt to changing market conditions and optimize returns.
What would affect this ETF?The Global X Adaptive U.S. Factor ETF (AUSF) could benefit from positive trends in the U.S. economy, such as strong consumer spending and technological innovation, which align with its exposure to sectors like Consumer Defensive and Technology. However, rising interest rates or economic slowdowns may negatively impact sectors like Financials and Industrials, which are significant components of the fund. Additionally, regulatory changes or market volatility could influence the performance of top holdings like AT&T and Johnson & Johnson.
AUSF Top 10 Holdings
AUSF is leaning into steady, cash-generating U.S. blue chips rather than high-flying growth names. Royalty Pharma has been a quiet engine for the fund, rising solidly this year, while Cisco and Walmart add more momentum with upbeat trends and growth stories in tech and retail. On the flip side, telecom giants Verizon and AT&T have been lagging recently, acting like a bit of a brake on returns. With all holdings U.S.-based and spread across health care, communication services, and consumer staples, the ETF feels diversified but tilted toward defensive, income-friendly leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Royalty Pharma | 2.46% | $21.22M | $28.49B | 52.58% | 79 Outperform | |
| Verizon | 2.33% | $20.10M | $195.62B | 11.11% | 81 Outperform | |
| AT&T | 1.96% | $16.87M | $182.97B | -6.38% | 71 Outperform | |
| Cisco Systems | 1.79% | $15.40M | $351.58B | 55.28% | 77 Outperform | |
| Altria Group | 1.62% | $13.95M | $111.78B | 13.42% | 64 Neutral | |
| Walmart | 1.61% | $13.87M | $1.04T | 33.99% | 78 Outperform | |
| Linde | 1.61% | $13.84M | $236.47B | 14.01% | 66 Neutral | |
| Johnson & Johnson | 1.55% | $13.35M | $547.64B | 45.05% | 78 Outperform | |
| CME Group | 1.51% | $13.05M | $103.42B | 5.23% | 74 Outperform | |
| TJX Companies | 1.50% | $12.89M | $173.80B | 23.87% | 79 Outperform |
AUSF Technical Analysis
Neutral
―
Price Trends
48.98
Negative
48.21
Positive
46.54
Positive
Market Momentum
0.09
Positive
48.40
Neutral
12.68
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AUSF, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 49.08, equal to the 50-day MA of 48.98, and equal to the 200-day MA of 46.54, indicating a neutral trend. The MACD of 0.09 indicates Positive momentum. The RSI at 48.40 is Neutral, neither overbought nor oversold. The STOCH value of 12.68 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AUSF.
AUSF Peer Comparison
Comparison Results
Performance Comparison
AUSF
Global X Adaptive U.S. Factor ETF
48.86
7.60
18.42%
SYLD
Cambria Shareholder Yield ETF
―
―
―
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
FDMO
Fidelity Momentum Factor ETF
―
―
―
HLAL
Wahed FTSE USA Shariah ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents